Published in Drug Week, October 3rd, 2008
Perlegen has already identified common genetic variants with proven, quantifiable associations to disease risk and drug response profiles, including common variants related to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.